What happens to intolerant, relapsed or refractory chronic myeloid leukemia patients without access to clinical trials?

por Bosi, Guilherme Rasia, Fogliatto, Laura Maria, Costa, Tito Emilio Vanelli, Grokoski, Kamila Castro, Pereira, Mariana Pinto, Bugs, Nathan, Kalil, Marco, Fraga, Christina, Daudt, Liane Esteves, Silla, Lucia Mariano da Rocha
Publicado 2019